
ABOUT US
At Quell we seek to discover, develop, and deliver pioneering Treg therapies to durably transform the lives of people suffering from immune-mediated diseases. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases.
OUR COMPANY
Quell is a London‑based clinical‑stage biotechnology company developing engineered regulatory T cell (Treg) therapies for immune‑mediated diseases. Its lead asset, QEL‑005, is a pipeline‑in‑a‑product for complex autoimmune diseases and is being evaluated in the Phase 1/2 CHILL clinical trial. Founded in 2019 with leading immunology experts from King’s College London, University College London and Hannover Medical School, Quell is backed by investors including Syncona, SV Health Investors, Jeito Capital, Ridgeback Capital and Fidelity.
THE ROLE
Research Associate – Technical Development
We are looking to recruit a Research Associate to expand our Technical Development team. The team is working very closely with Research and Development department and will contribute to creation of best ways of manufacturing process to help to develop our CAR-Treg therapies and will be involved in generating next generation products.
The individual will be working very closely with R&D, internal and external manufacturing teams while participating in the effective running of daily operations process development team and will contribute to creation of best ways of manufacturing process to help to develop our CAR-Treg therapies.
This position offers an excellent opportunity for a talented and motivated technician to contribute to a key part of our work. Quell offers an exciting and highly dynamic environment focused on developing cutting-edge Treg therapies.
The role requires being onsite 5 days per week and will require flexibility to travel between both London sites (White City and London Bridge)
MAIN RESPONSIBILITIES
ESSENTIAL SKILLS AND EXPERIENCE
PERSONAL QUALITIES
BENEFITS
PERKS

An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.
Our company is growing and we are exciting about the future! Our vision is to become a world leader in new cell therapy and the people are at the heart of what we do. We treat our people with respect, working collaboratively across the business, taking ownership and accountability for the outcomes and results we delivery. Most of all we work with integrity to innovate and bring the best version of ourselves to the job every day.